| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 56.34B | 58.27B | 47.41B | 82.33B | 78.95B |
| Gross Profit | 5.89B | 5.65B | 4.90B | 8.35B | 9.00B |
| EBITDA | 4.30B | 3.65B | 4.01B | 7.77B | 7.67B |
| Net Income | 1.42B | 1.54B | 804.03M | 3.58B | 5.75B |
Balance Sheet | |||||
| Total Assets | 43.79B | 42.70B | 42.12B | 45.33B | 48.16B |
| Cash, Cash Equivalents and Short-Term Investments | 6.42B | 6.58B | 6.52B | 9.29B | 9.91B |
| Total Debt | 11.53B | 11.49B | 10.86B | 11.76B | 10.10B |
| Total Liabilities | 23.63B | 23.62B | 22.01B | 24.08B | 23.33B |
| Stockholders Equity | 17.72B | 16.76B | 17.59B | 18.43B | 21.04B |
Cash Flow | |||||
| Free Cash Flow | 2.28B | 2.16B | 2.13B | 3.94B | 4.19B |
| Operating Cash Flow | 2.92B | 2.87B | 2.95B | 5.56B | 5.93B |
| Investing Cash Flow | -325.23M | -777.19M | -1.75B | -574.03M | 10.80B |
| Financing Cash Flow | -2.96B | -2.13B | -3.69B | -4.15B | -15.65B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | HK$45.10B | 11.05 | 9.96% | 6.39% | -8.51% | 9.94% | |
75 Outperform | HK$92.01B | ― | 7.60% | ― | 18.89% | 6.97% | |
74 Outperform | HK$137.67B | 11.17 | 14.02% | 3.05% | 11.02% | 4.17% | |
67 Neutral | HK$196.49B | 15.39 | 11.60% | 2.77% | 10.09% | 7.87% | |
65 Neutral | HK$11.53B | 4.20 | 8.00% | 3.55% | -3.33% | -8.42% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
58 Neutral | HK$81.06B | 25.39 | 6.50% | ― | 18.42% | 97.52% |